on Nasdaq Stockholm AB since December 12, 2017 and is included in the Nasdaq Nordic Large Cap segment. The total amount of shares in Arjo is 272,369,573, whereof 18,217,200 shares of series A and 254,152,373 shares of series B.

Empowering movement is fundamental to any patient rehabilitation programme and is a core principle in the prevention of pressure injury development. With the impact of the current pandemic, the focus on mobilising and rehabilitating patients

access when performing activities such as dressing, foot care, wound care and leg dressings. It is a patient specific product and should be used for a limited period only.

Transporting patients on hospital beds is an ergonomically high risk activity for caregivers. However, the use of powered assisted beds can have a positive impact on their work lives. Read an extract from 'A case for powered bed transport' whitepaper

About Arjo - For investors, shareholders and analysts Investors Arjo investor relations. Market-leading supplier of medical devices and solutions for patients with reduced mobility and age-related diseases. Visit us today!

Guide for Arjo Guide for Architects and Planners Space to move safely. When designing a healthcare facility, this critical need is often overlooked, resulting in a whole range of problems. From difficulties navigating beds and congested corridors

patients in a supine position from one flat surface to another. The sling dimensions fit with the Arjo bariatric beds. It is designed to accompany a patient throughout the hospital stay and can be used in exactly the same way as a standard bariatric